Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI - Wikidata - wikimedia - TriplyDB

Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI

Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI

http://www.wikidata.org/entity/Q35946168

about

Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology Focused ultrasound simultaneous irradiation/MRI imaging, and two-stage general kinetic model.A simulation tool for dynamic contrast enhanced MRI.Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.An efficient computational approach to characterize DSC-MRI signals arising from three-dimensional heterogeneous tissue structures The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test.Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.Magnetic resonance imaging of brain angiogenesis after stroke In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.Long-term vascular access ports as a means of sedative administration in a rodent fMRI survival model High-field small animal magnetic resonance oncology studies.T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors.MRI measurements of vessel calibre in tumour xenografts: comparison with vascular corrosion casting Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy Imaging the microvessel caliber and density: Principles and applications of microvascular MRI.Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.Vascular permeability in the RG2 glioma model can be mediated by macropinocytosis and be independent of the opening of the tight junction.Simultaneous assessment of vessel size index, relative blood volume, and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis.Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches.A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.Assessment of a combined spin- and gradient-echo (SAGE) DSC-MRI method for preclinical neuroimaging.In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology.Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.MR evaluation of vessel size imaging of human gliomas: Validation by histopathology.Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment.Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters.

P2860

Q21560786-4F4B1F8C-AC9D-4DAD-98A7-75629643C26B Q26776191-483144E8-5294-4269-87E8-44544A08654D Q30436125-441699CE-00A6-4EF2-BB1B-257F26BFD3F3 Q30604706-19FA06C7-A01F-48E7-884B-BDCE1957D005 Q30651792-05054205-AA0E-44E7-BC14-528104BBE371 Q30731774-547E218A-0821-4756-835D-F0F677D68C5B Q30809060-094BD5E2-FF81-42DD-90B6-A6CF2005F803 Q30930089-159E0381-D4B4-463B-8E32-8A56AC99EDF3 Q30930526-F191DAD1-D530-46E9-B112-CB1D1B72FF08 Q31133294-3B87F62E-B5A4-4613-BCA9-4003E917B939 Q33605839-2A4CEE66-1DAF-4E16-B064-0A25E249597E Q33799575-40767115-34E6-4256-8529-798A4FBD1F1E Q33933312-D890D6DC-2D9B-4F55-BD09-284932608722 Q34331739-5AAB1059-1854-4B9C-AF18-6729BB9A577F Q34794677-ECC89369-0E51-4073-A8EF-00BE129A0F08 Q35148152-8454BBEA-3F5F-41B3-B19E-D30BA1DFB0BD Q35165274-34A2526E-B713-4093-B4FD-2022E70ECC10 Q35312455-04FBDAFD-47CA-4052-98C4-D187194135E3 Q35524040-D76DF07C-5843-46B7-AD7C-0C4C7D140F14 Q36289257-B35A9859-F7A5-47C6-90E2-B27DE8139AED Q36596242-CCFAF485-461B-4A97-8253-601638428A81 Q36852895-613CA6D2-8119-4650-A168-379858040DF5 Q37025641-3D4F47B1-96D9-424E-837B-E06EB0EDF505 Q37161504-C47505C7-0634-4308-B1CE-CF456EFF2C39 Q38244289-42C5F3A6-2510-498C-B943-2C3C11C80BD2 Q38376846-81D4E4A7-518F-4CCF-AF22-524C1820809A Q38764263-78AF0EA2-DBF1-424A-9072-080F5FF87E73 Q39037255-AD860B52-99D5-4F9F-854A-9D792CA72027 Q39351705-2E007986-3389-41F2-9479-4F7788E9D227 Q39507583-C50E6935-FB4B-4025-94DF-0BACCFD1FB2D Q41110202-CC49AF94-EF60-4870-B65D-43F1BAF7CFDF Q42112303-3698AA54-275E-422C-B8C1-12E86C416A2E Q43980822-5C6A9783-97D8-414F-A63C-4C5DE2105FA9 Q47367815-4CA3650C-B8EC-4B66-8A92-69A1D33EE061 Q47405585-0998C64B-D105-477A-947A-C52A6B26A26D Q47843849-1756824A-E49E-48C0-9E03-47B94901704F Q55456663-65FB0C00-CB1E-4FE0-BA53-92BA10004993

P2860

Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI

http://www.wikidata.org/entity/Q35946168

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@ast

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@en

type

label

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@ast

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@en

prefLabel

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@ast

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@en

P1433

Q35946168-28C70FB4-D095-44FF-BD5B-DEBBEBBF6E9D

P1476

Q35946168-B7ECE1CA-A02A-4A52-9BB1-AA0A79818C36

P2093

Q35946168-156D44E3-6355-44FB-9EB7-6AC5490A5A81

Q35946168-8394D423-7EC7-4D68-8B7E-97C759FEDBAA

Q35946168-AC0BECAD-94FE-4634-9390-EFE6149211FA

Q35946168-EF0A3BE2-C64D-47F3-A417-2F486EF3DC1D

P2860

Q35946168-0A5334D4-8DED-42F9-83E4-1D12F335EF0D

Q35946168-1778A634-0947-4803-9035-B65B1B387717

Q35946168-1C634A28-6586-451F-AB17-7BFC6398EB61

Q35946168-1EB69AFB-3822-4D4D-8A12-E500F6710BAB

Q35946168-2470EAF4-AC46-4288-8B44-813214A7A3F8

Q35946168-28654427-DB21-407C-8ABD-ACCF464A692F

Q35946168-2A23F2D7-2E5F-489B-B25E-FC9133EB07D7

Q35946168-2C4E7D69-B471-4489-A4E3-4140BC5BD5C6

Q35946168-2E01913B-C3F7-4891-AF86-79E028966EC9

Q35946168-3B210258-8835-471A-AD94-EE7128DD4A81

P304

Q35946168-5127FB7E-84A2-4CCC-98D7-096E663412AA

P31

Q35946168-2EE8477E-8B78-4FC5-BA5D-5BE5DD11608F

P356

Q35946168-CC9E4CC1-8E59-4E04-A2DC-9C820187CB81

P433

Q35946168-9D2FD1E0-7B80-47C9-9BC6-F0001BF833E0

P478

Q35946168-8F3E1B44-CE54-429B-A9BD-4C2375952378

P50

Q35946168-69B57E8C-1A4A-4462-BC9A-97524D84482F

Q35946168-7C257EE4-3683-4F50-A656-BC6F0786F5D9

P577

Q35946168-9E4A777E-FC8D-477A-9598-698C384845E3

P5875

Q35946168-F60C551F-0A5B-4062-9D4A-A5E2737C99FE

P698

Q35946168-7A1D5963-AEEB-486D-8ECC-04C472FF0EA5

P932

Q35946168-EB20F5B0-A4F5-4236-9AED-5BF76C2D3DB2

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Characterization of tumor angi ...... dynamic contrast-enhanced MRI

@en

P2093

Chantal Rémy

http://www.w3.org/2001/XMLSchema#string

Christoph Segebarth

http://www.w3.org/2001/XMLSchema#string

Marine Beaumont

http://www.w3.org/2001/XMLSchema#string

Régine Farion

http://www.w3.org/2001/XMLSchema#string

P2860

Angiogenesis in cancer and other diseases

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Methodology of brain perfusion imaging.

Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.

Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease.

Angiogenesis in gliomas: imaging and experimental therapeutics.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.

Management of malignant glioma: steady progress with multimodal approaches.

Recurrent glioblastoma multiforme: a review of natural history and management options.

P304

1714-1726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2009.86

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin Lemasson

Emmanuel L Barbier

P577

2009-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26654345

http://www.w3.org/2001/XMLSchema#string

P698

19584891

http://www.w3.org/2001/XMLSchema#string

P932

3348120

http://www.w3.org/2001/XMLSchema#string